Page last updated: 2024-09-05

schaftoside and Reperfusion Injury

schaftoside has been researched along with Reperfusion Injury in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, Z; Wu, M; Zhang, L	1

Other Studies

1 other study(ies) available for schaftoside and Reperfusion Injury

Article	Year
Schaftoside improves cerebral ischemia-reperfusion injury by enhancing autophagy and reducing apoptosis and inflammation through the AMPK/mTOR pathway. Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2022, Volume: 31, Issue:12 Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Autophagy; Glycosides; Inflammation; Mammals; Neuroprotective Agents; Oxygen; Rats; Reperfusion Injury; TOR Serine-Threonine Kinases	2022

Article

Year

Schaftoside improves cerebral ischemia-reperfusion injury by enhancing autophagy and reducing apoptosis and inflammation through the AMPK/mTOR pathway.

Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2022, Volume: 31, Issue:12

Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Autophagy; Glycosides; Inflammation; Mammals; Neuroprotective Agents; Oxygen; Rats; Reperfusion Injury; TOR Serine-Threonine Kinases

2022